person · Reporting owner
Kassler-Taub Kenneth B.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC.LXRX · Entity 4970 | SVP, Regulatory & QA | February 28, 2024 | February 29, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEXICON PHARMACEUTICALS, INC.
Report date February 28, 2024 · Filed February 29, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 162,672 |
Ending reported balance
After 2024-02-28 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2024-02-28 · Exercise / conversion · Acquired 7,087 · Balance 126,712 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. Row 2 · 2024-02-28 · Exercise / conversion · Acquired 27,556 · Balance 154,268 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. Row 3 · 2024-02-28 · Exercise / conversion · Acquired 32,757 · Balance 187,025 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. Row 4 · 2024-02-28 · Tax withholding · Disposed 24,353 · Balance 162,672 F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-02-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-02-28 · Exercise / conversion · Disposed 7,087 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 27,557 |
Reported balance
After 2024-02-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-02-28 · Exercise / conversion · Disposed 27,556 · Balance 27,557 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 65,513 |
Reported balance
After 2024-02-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2024-02-28 · Exercise / conversion · Disposed 32,757 · Balance 65,513 F1: Each restricted stock unit represents a contingent right to receive one share of common stock. F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of common stock.
F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2024 Filed Feb 29, 2024 21:29 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 32,757 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007621 · form4.xml · derivative · entry 7 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,513 Underlying: Common Stock · 32,757 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:29 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 27,556 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007621 · form4.xml · derivative · entry 6 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,557 Underlying: Common Stock · 27,556 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:29 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 7,087 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007621 · form4.xml · derivative · entry 5 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,087 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:29 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 24,353 | $2.62 | $63,804.86 |
DisclosureSEC source: 0001127602-24-007621 · form4.xml · nonDerivative · entry 4 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,672 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:29 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 32,757 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007621 · form4.xml · nonDerivative · entry 3 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:29 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 27,556 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007621 · form4.xml · nonDerivative · entry 2 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,268 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:29 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 7,087 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007621 · form4.xml · nonDerivative · entry 1 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,712 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 203,810 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001127602-24-004464 · form4.xml · derivative · entry 2 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,810 Underlying: Common Stock · 203,810 shares Expires 2034-02-08 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 203,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004464 · form4.xml · derivative · entry 1 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,810 Underlying: Common Stock · 203,810 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:51 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 27,557 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007925 · form4.xml · derivative · entry 7 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,113 Underlying: Common Stock · 27,557 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:51 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 7,086 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007925 · form4.xml · derivative · entry 6 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,087 Underlying: Common Stock · 7,086 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:51 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 18,243 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007925 · form4.xml · derivative · entry 5 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,243 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:51 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 19,118 | $2.17 | $41,486.06 |
DisclosureSEC source: 0001127602-23-007925 · form4.xml · nonDerivative · entry 4 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,625 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:51 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 27,557 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007925 · form4.xml · nonDerivative · entry 3 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:51 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 7,086 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007925 · form4.xml · nonDerivative · entry 2 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,186 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 21:51 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 18,243 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-007925 · form4.xml · nonDerivative · entry 1 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:00 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 294,810 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001127602-23-004931 · form4.xml · derivative · entry 2 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,810 Underlying: Common Stock · 294,810 shares Expires 2033-02-09 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:00 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 98,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-004931 · form4.xml · derivative · entry 1 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,270 Underlying: Common Stock · 98,270 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 7,087 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007172 · form4.xml · derivative · entry 7 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,173 Underlying: Common Stock · 7,087 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F4 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 18,244 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007172 · form4.xml · derivative · entry 6 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,243 Underlying: Common Stock · 18,244 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F4 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 11,297 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007172 · form4.xml · derivative · entry 5 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,297 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. F3 · derivative.expiration_date: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Tax withholdingCommon Stock | 13,241 | $2.85 | $37,736.85 |
DisclosureSEC source: 0001127602-22-007172 · form4.xml · nonDerivative · entry 4 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,857 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 7,087 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007172 · form4.xml · nonDerivative · entry 3 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,098 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 18,244 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007172 · form4.xml · nonDerivative · entry 2 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 00:15 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 11,297 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-007172 · form4.xml · nonDerivative · entry 1 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:06 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 82,670 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004761 · form4.xml · derivative · entry 2 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,670 Underlying: Common Stock · 82,670 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:06 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 248,010 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001127602-22-004761 · form4.xml · derivative · entry 1 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,010 Underlying: Common Stock · 248,010 shares Expires 2032-02-10 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.